Consolidated Statements of Operations (Unaudited) - USD ($) $ in Thousands		3 Months Ended		9 Months Ended
		Sep. 30, 2018	Sep. 30, 2017	Sep. 30, 2018	Sep. 30, 2017
Income Statement [Abstract]
REVENUES		$ 769	$ 718	$ 2,779	$ 1,927
COST OF REVENUES		571	565	2,011	1,553
GROSS PROFIT		198	153	768	374
OPERATING EXPENSES:
Research and development		416	288	898	1,041
Selling and marketing		605	671	1,677	1,835
General and administrative		1,156	1,279	3,598	4,281
Total operating expenses		2,177	2,238	6,173	7,157
LOSS FROM OPERATIONS		(1,979)	(2,085)	(5,405)	(6,783)
FINANCIAL EXPENSES (Income), net:
Interest expenses					119
Other financial expenses (income)		32	1	(378)	36
Total financial expenses (income)		32	1	(378)	155
LOSS BEFORE TAX EXPENSES		(2,011)	(2,086)	(5,027)	(6,938)
TAX EXPENSES					1
NET LOSS		$ (2,011)	$ (2,086)	$ (5,027)	$ (6,939)
NET LOSS PER SHARE - basic and diluted		$ (0.05)	$ (6.56)	$ (0.32)	$ (30.42)
WEIGHTED AVERAGE NUMBER OF COMMON STOCK USED IN COMPUTING NET LOSS PER SHARE - Basic and diluted	[1]	40,764,158	317,896	16,729,052	248,907

[1] For the purpose of calculating basic net loss per share, the additional shares of common stock that are issuuaable upon exercise of the Pre-funded Warrants have been included since the shares are issuable for a negligible consideration, as determined by the Company according to ASC 260-10-45-13, and have no vesting or other contingencies associated with them. 3,316,666 pre-funded warrants are included in the three and nine month calculation.